[go: up one dir, main page]

FR2828687B1 - Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat - Google Patents

Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat

Info

Publication number
FR2828687B1
FR2828687B1 FR0115424A FR0115424A FR2828687B1 FR 2828687 B1 FR2828687 B1 FR 2828687B1 FR 0115424 A FR0115424 A FR 0115424A FR 0115424 A FR0115424 A FR 0115424A FR 2828687 B1 FR2828687 B1 FR 2828687B1
Authority
FR
France
Prior art keywords
cats
infection
novel peptides
medicaments against
ivf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0115424A
Other languages
English (en)
Other versions
FR2828687A1 (fr
Inventor
Pierre Francois Serres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HIPPOCAMPE
Original Assignee
HIPPOCAMPE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0110910A external-priority patent/FR2828686B1/fr
Application filed by HIPPOCAMPE filed Critical HIPPOCAMPE
Priority to FR0115424A priority Critical patent/FR2828687B1/fr
Priority to PCT/US2002/026247 priority patent/WO2003015814A1/fr
Publication of FR2828687A1 publication Critical patent/FR2828687A1/fr
Application granted granted Critical
Publication of FR2828687B1 publication Critical patent/FR2828687B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR0115424A 2001-08-17 2001-11-29 Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat Expired - Fee Related FR2828687B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0115424A FR2828687B1 (fr) 2001-08-17 2001-11-29 Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
PCT/US2002/026247 WO2003015814A1 (fr) 2001-08-17 2002-08-19 Nouveaux peptides et utilisation de ceux-ci en tant qu'agents therapeutiques contre l'infection par le virus de l'immunodeficience feline (fiv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0110910A FR2828686B1 (fr) 2001-08-17 2001-08-17 Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
FR0115424A FR2828687B1 (fr) 2001-08-17 2001-11-29 Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat

Publications (2)

Publication Number Publication Date
FR2828687A1 FR2828687A1 (fr) 2003-02-21
FR2828687B1 true FR2828687B1 (fr) 2003-12-12

Family

ID=26213149

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0115424A Expired - Fee Related FR2828687B1 (fr) 2001-08-17 2001-11-29 Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat

Country Status (2)

Country Link
FR (1) FR2828687B1 (fr)
WO (1) WO2003015814A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026733A1 (fr) 2003-09-11 2005-03-24 Idexx Laboratories, Inc. Procede et dispositif permettant de detecter le virus de l'immunodeficience feline
DE602004021724D1 (de) 2003-12-18 2009-08-06 Idexx Lab Inc Verfahren zum nachweis des felinen immunschwächevirus
ATE504834T1 (de) 2004-02-19 2011-04-15 Idexx Lab Inc Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus
US7285278B2 (en) 2004-06-30 2007-10-23 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
AU2005267608B2 (en) 2004-06-30 2009-01-15 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (FIV) comprising the use of peptides derived from the V3 region of the FIV env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2011123781A1 (fr) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Détection du virus de l'immunodéficience féline

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341439C (fr) * 1987-08-26 2003-09-23 Niels C. Pedersen Lentivirus t-lymphotrope felin
US6107077A (en) * 1987-08-26 2000-08-22 Yamamoto; Janet K. Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines
US5223421A (en) * 1989-10-25 1993-06-29 The General Hospital Corporation Identification of methionine Nα-acetyltransferase
CA2111325C (fr) * 1991-06-14 2007-10-23 Bruce Ernest Kemp Detection des virus de l'immunodeficience des mammiferes
US5736378A (en) * 1991-09-12 1998-04-07 The Scripps Research Institute Molecular cloning and characterization of the feline immunodeficiency virus isolate PPR
ATE278018T1 (de) * 1992-06-16 2004-10-15 Centre Nat Rech Scient Nukleotid- und peptidsequenzen des immunschwächevirus der katze, isolat wo und anwendungen der sequenzen in der diagnostik und zur verhinderung der infektion
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines

Also Published As

Publication number Publication date
WO2003015814A1 (fr) 2003-02-27
FR2828687A1 (fr) 2003-02-21

Similar Documents

Publication Publication Date Title
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
AU2002366306A1 (en) Animal breeding system and utilization of the system
DK1142566T3 (da) Oftalmologiske formuleringer på basis af ciclosporin, hyaluronsyre og polysorbat
EP1663959A4 (fr) Nouveaux composes d'amidine dans le traitement d'infections microbiennes
DE69819124D1 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
AU2001270484A1 (en) Use of bradycardiac substances in the treatment of myocardial diseases associated with hypertrophy and novel medicament combinations
FR2828687B1 (fr) Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
AU2002322519A1 (en) Proteins associated with cell growth, differentiation, and death
AU2001267515A1 (en) Mammalion haemoglobin compatible with blood plasma, cross-linked and conjugated with polyalkylene oxides as artificial medical oxygen carriers, production and use thereof
EP1175228A4 (fr) Therapie genique reposant sur l'utilisation du tgf-beta
FR2828686B1 (fr) Nouveaux peptides et leur utilisation comme medicaments contre l'infection par le fiv chez le chat
AU2001274566A1 (en) Novel protein and dna thereof
AU2001277696A1 (en) Novel physiologically active peptide and use thereof
AU2002320022A1 (en) Proteins associated with cell growth, differentiation, and death
AU2002236984A1 (en) Proteins associated with cell growth, differentiation, and death
AU3609800A (en) Novel formulations of alkyllithiums with improved thermal stability, processes to produce these formulations and processes for using the same to improve stability of living polymer chain ends
AU2002357557A1 (en) Targeted hydrophilic polymer, binders with interferon and medical composite comprising above binders
AU2002338509B2 (en) Improvements in and relating to the administration of copper to an animal
AU2002320089A1 (en) Proteins associated with cell growth, differentiation, and death
AU4544600A (en) Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
AU2002252773A1 (en) Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379
AU2002330157A1 (en) Proteins associated with cell growth, differentiation, and death
AU2001248750A1 (en) Novel physiologically active peptides and use thereof
EP1139913A4 (fr) Composition et formulations et leur utilisation comme nociceptifs, anti-anxiolytiques et anabolisants
FR2794763B1 (fr) Nouveaux derives de l'acide hyaluronique, leur preparation et leur utilisation

Legal Events

Date Code Title Description
CD Change of name or company name
CJ Change in legal form
SN Distraint notified (in the national patent register)
ST Notification of lapse